Stay updated on Avelumab and Palbociclib in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.

Latest updates to the Avelumab and Palbociclib in Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedThe clinical trial for Avelumab or Hydroxychloroquine with or without Palbociclib to eliminate dormant breast cancer (PALAVY) has been updated to a new date of March 11, 2025, replacing the previous date of March 12, 2024.SummaryDifference1.0%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check50 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check71 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
Stay in the know with updates to Avelumab and Palbociclib in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.